Please login to the form below

Not currently logged in
Email:
Password:

Amgen promotes Michael Severino to chief medical officer

He will also take over senior VP global development role from Sean Harper, who is promoted to executive VP, R&D

Michael Severino has been promoted to the dual role of senior VP, global development and corporate chief medical officer at Amgen.

The former VP of global development, Severino will take over from Sean Harper who has been appointed executive VP, R&D at the US biotech.

Harper's appointment was announced in December, 2011, at the same time as CEO Kevin Sharer declared his intention to step down this May.

Severino has spent eight years at Amgen, where he also served as senior director of inflammation early development and head of the company's proof-of-concept group within medical sciences.

His previous experience includes several years at Merck Research Laboratories working across a wide range of therapeutic areas including vaccines, oncology, diabetes and neurosciences.

"Since joining Amgen in 2004, Mike has demonstrated leadership across Amgen's global development organisation and has made significant contributions to the overall advancement of Amgen's pipeline," said Harper.

"Mike brings broad experience and immense expertise to his new role and I am confident that under his leadership, Amgen's global development team will continue to deliver important new medicines for patients with serious illnesses."

Harper joined Amgen in 2002 as vice president of development, and during his time at the company established its medical sciences capability to focus on translational medicine research.

Like Severino, he also has previous experience at Merck Research Laboratories. He is also a member of the PhRMA Regulatory Affairs Coordinating Committee.

16th February 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...